New York University Skip to Content Skip to Search Skip to Navigation Skip to Sub Navigation

NIH Grant Using Genomics to Tailor Oral Cancer Treatment Awarded to Dr. Brian L. Schmidt, NYU College of Dentistry, and Dr. Donna G. Albertson, University of California, San Francisco

April 25, 2012
N-350, 2011-12

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has awarded a two-year grant to Dr. Brian L. Schmidt, professor of oral and maxillofacial surgery at the NYU College of Dentistry, and Dr. Donna G. Albertson, professor at the UCSF Helen Diller Family Comprehensive Cancer Center.  The grant will fund groundbreaking research to customize treatment for oral cancer patients.  Drs. Schmidt and Albertson have identified candidate genomic markers in tumors that predict if an oral cancer is likely to spread (metastasize) to the neck.

Oral cancer is often fatal if it spreads to the neck and remains untreated. Current clinical and radiographic examination provides limited information for diagnosis of early neck metastasis of oral cancer. Nearly all cancers within the oral cavity must be surgically removed.  An additional and extensive surgery (neck dissection) is also performed to remove lymphatic tissue in the neck if there is any clinical or radiographic evidence of neck metastasis.  Patients who present with no evidence of metastasis in the neck often undergo a preemptive neck surgery because untreated occult (hidden) metastasis reduces life expectancy by half.

The work of Drs. Schmidt and Albertson will validate genomic markers that will ultimately be used to rule out neck dissection in oral cancer patients with no clinical evidence of neck metastasis and who have tumors containing specific genomic profiles.  Dr. Alberston notes, “It has taken us eight years of research to converge on a genomic marker that could be used to tailor treatment for oral cancer patients.  We look forward to testing this marker in a clinical study and this funding will help up us to develop the appropriate laboratory test for such a trial.”

Currently, neck surgery for those suffering from oral cancer entails a three-to-four hour major procedure involving critical anatomic structures and is associated with life altering morbidity including stroke. For most patients this procedure is unneeded but employed as a pragmatic solution to the dilemma posed by the specter of occult metastasis. Dr. Schmidt states, “We can dramatically improve quality of life if we can accurately identify those who do not need a neck dissection.  Morbidity and recovery time would be reduced, and we would alleviate anxiety for many patients and families.”

Dr. Schmidt will conduct the clinical portion of the study through the NYU Bluestone Center for Clinical Research, which he directs. Dr. Schmidt and his team will recruit subjects, enroll patients, and collect the specimens. The samples will then be sent to the UCSF Helen Diller Family Comprehensive Cancer Center where Dr. Albertson’s group will process and analyze the samples. Drs. Schmidt and Albertson foresee improved care for oral cancer patients once their newly identified genomic marker is validated.

About New York University College of Dentistry:

Founded in 1865, New York University College of Dentistry (NYUCD) is the third oldest and the largest dental school in the US, educating more than 8 percent of all dentists. NYUCD has a significant global reach and provides a level of national and international diversity among its students that is unmatched by any other dental school.

 

This Press Release is in the following Topics:
Research, Research News, College of Dentistry

Type: Press Release

Press Contact: Christopher James | (212) 998-6876

NIH Grant Using Genomics to Tailor Oral Cancer Treatment Awarded to Dr. Brian L. Schmidt, NYU College of Dentistry, and Dr. Donna G. Albertson, University of California, San Francisco

LEFT: Dr. Donna G. Albertson, professor at the UCSF Helen Diller Family Comprehensive Cancer Center and Dr. Brian L. Schmidt, professor of oral and maxillofacial surgery at the NYU College of Dentistry


Search News



NYU In the News

Entrepreneurship Lab Opens at NYU

Crain’s New York Business covered the opening of the Mark and Debra Leslie Entrepreneurial eLab, which will be the headquarters for NYU’s Entrepreneurial Institute and all of the University’s programs aimed at promoting innovation and startups.

A Globalizer for N.Y.U. in Abu Dhabi

The New York Times profiled Bill Bragin who will become the first executive artistic director of NYU Abu Dhabi’s new performing arts center.

Think Tank to Ponder a Future for Ballet

The New York Times profiled Jennifer Homans, the director of NYU’s new Center for Ballet and the Arts.

The Brilliant Ten: Jonathan Viventi Builds Devices That Decode Thoughts

Popular Science named Assistant Bioengineering Professor Jonathan Viventi as one of its “brilliant ten” for his research into brain implants that could one day halt epileptic episodes:

Living and Leaving the Dream: Adrian Cardenas’ Journey from the Major Leagues to College

The New York Times ran a feature on Adrian Cardenas, a former major league baseball player who is now studying philosophy and creating writing at NYU.

NYU Footer